Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension - Wikidata - awgldk - TriplyDB

Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension

Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension

http://www.wikidata.org/entity/Q36016893

about

Noninvasive intraocular pressure monitoring: current insights Strategies for improving early detection of glaucoma: the combined structure-function index Is 24-hour intraocular pressure monitoring necessary in glaucoma?Oral microbiome link to neurodegeneration in glaucoma Predicting progression of glaucoma from rates of frequency doubling technology perimetry change Comparison of HRT-3 glaucoma probability score and subjective stereophotograph assessment for prediction of progression in glaucoma.Diagnostic tools for glaucoma detection and management.The African Descent and Glaucoma Evaluation Study (ADAGES): design and baseline data.Relationship between pattern electroretinogram, standard automated perimetry, and optic nerve structural assessments A new method for determining physician decision thresholds using empiric, uncertain recommendations.Determinants of agreement between the confocal scanning laser tomograph and standardized assessment of glaucomatous progression.Predicting the onset of glaucoma: the confocal scanning laser ophthalmoscopy ancillary study to theOcular Hypertension Treatment Study.Using CorvisST tonometry to assess glaucoma progression.Development of a risk score for geographic atrophy in complications of the age-related macular degeneration prevention trial.Prediction of functional loss in glaucoma from progressive optic disc damage Incorporating mortality risk into estimates of 5-year glaucoma risk Long-term intraocular pressure fluctuations and risk of conversion from ocular hypertension to glaucoma.Developing the clinical components of a complex intervention for a glaucoma screening trial: a mixed methods study.Glaucoma: genes, phenotypes, and new directions for therapy.Effect of dorzolamide/timolol combination on the visual field in glaucoma.Effect of 3 years of treatment with a dorzolamide/timolol (1%/0.5%) combination on intraocular pressure.The effect of changes in intraocular pressure on the risk of primary open-angle glaucoma in patients with ocular hypertension: an application of latent class analysis The Heidelberg retina tomograph ancillary study to the European glaucoma prevention study: study design and baseline factors.Distribution of central corneal thickness and its association with ocular parameters in a large central European cohort: the Gutenberg health study.Evaluation of progressive neuroretinal rim loss as a surrogate end point for development of visual field loss in glaucoma.The accuracy and clinical application of predictive models for primary open-angle glaucoma in ocular hypertensive individuals.Clinical characteristics and current treatment of glaucoma.Adjusting intraocular pressure for central corneal thickness does not improve prediction models for primary open-angle glaucoma.A Joint Model for Prognostic Effect of Biomarker Variability on Outcomes: long-term intraocular pressure (IOP) fluctuation on the risk of developing primary open-angle glaucoma (POAG)Expression of glucose transporters in the prelaminar region of the optic-nerve head of the pig as determined by immunolabeling and tissue culture Stereo Photo Measured ONH Shape Predicts Development of POAG in Subjects With Ocular Hypertension Effect of treatment on the rate of visual field change in the ocular hypertension treatment study observation group.Baseline factors predicting the risk of conversion from ocular hypertension to primary open-angle glaucoma during a 10-year follow-up.Stratification of phaco-trabectome surgery results using a glaucoma severity index in a retrospective analysis.Risk of Ocular Hypertension in Adults with Noninfectious Uveitis.A validated risk calculator to assess risk and rate of visual field progression in treated glaucoma patients.Predicting Development of Glaucomatous Visual Field Conversion Using Baseline Fourier-Domain Optical Coherence Tomography.Spectral analysis of intraocular pressure pulse wave in ocular hypertensive and primary open angle glaucoma patients Predicting development of proliferative diabetic retinopathy Predicting progression in glaucoma suspects with longitudinal estimates of retinal ganglion cell counts.

P2860

Q26800246-4CE7F96F-3A8B-4C68-948F-58C3B5B2A56F Q26997010-F877BCEB-D6FA-405B-8E2C-F9EC12629522 Q27014089-819706A3-9CC7-4D9B-BEC8-0EB1BD6C5871 Q27316016-055D0FA1-0C4B-46BC-9209-D07C315FE5D7 Q31144659-9F5D0E52-B749-40BE-BA4D-AF5E0B91BA65 Q33330813-58179E31-346B-498E-945C-927899667871 Q33387777-BAC9783F-A219-4573-BEF4-CFA1193EF49A Q33502968-C77F12E7-F317-444B-863F-12A2224ACFDB Q33510330-75A35589-0D41-4483-9F58-35B8E456A979 Q33551018-6566707F-B30A-4BAA-814D-19622743342D Q33608338-8746F616-29E6-4A8E-87F7-602B96E57AE0 Q33633604-8D671271-9D30-40DB-9096-5BB43E9E59BA Q33637599-BA703EB6-37BB-4F30-B5A8-D254A04B5BDC Q33676775-BDF2D46F-1C01-45F4-8644-8B39CBBA5F8A Q33687236-A81792B9-5282-451D-936D-B2710EE3F742 Q33694660-1C478FBD-6C1C-4106-B052-D79365A355C6 Q33764018-AFD9D551-CBA5-4411-B2A8-573B138C10EA Q33878922-A002DE70-BFEE-491B-9DA7-FB8D293BC27B Q34090204-22675AF5-B70A-4AC3-B1BB-CB203CFB5591 Q34134877-3D3018A0-41CE-4FED-9D08-7401DB72EA79 Q34182293-C4C4FD09-29AF-4A4C-B9E3-4682A3ABE2B2 Q34433542-D5CB324A-6D77-4814-8E7C-1EC09E7C909B Q34741660-B7A3E381-4C34-40EB-A90E-33A7D4EED3F0 Q34923866-01B45EC0-F569-4D87-8741-1A24DB36FDBA Q34944081-2030BE94-C2CF-4DCB-A97D-B65C8877FDEF Q35052597-A33D6472-4B4B-44AD-A683-D8E372D9CDE2 Q35180374-23EC70F9-6F13-499F-81F5-851B028B79B7 Q35250502-4F7D07AE-53C2-42DF-9E5F-C9244A898538 Q35612531-E25244F2-54D8-4480-AA28-A79E1FC98F59 Q35647692-07774C7C-51C6-4F07-865D-5078F12AE120 Q35870341-40F6C1CE-636D-4DE4-927E-D2F0C4D3DD0A Q35929958-F72F2DA5-457F-4D97-8A3B-13D0ECC82A29 Q36016475-34FCC5FA-D48E-4EB6-B566-C70D87AAAAF7 Q36317555-F72898D5-F19F-430A-85A7-C559A88858BC Q36354205-04B47D1B-F759-47C3-84FE-2A8340438C81 Q36390585-4FDDA2FA-0F12-4824-8252-071B1F8F153E Q36627014-A335CD46-1EAD-4919-9C3F-579E0FE8440E Q36851244-F9A4E940-EFE6-4B62-9D85-F35F829F31F5 Q36868163-F927EB04-29B6-4BC7-8807-5FC7C43795FC Q36943814-ACDCEE32-CDE7-47D4-B9BB-C4798A1031D8

P2860

Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension

http://www.wikidata.org/entity/Q36016893

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Validated prediction model for ...... duals with ocular hypertension

@ast

Validated prediction model for ...... duals with ocular hypertension

@en

type

label

Validated prediction model for ...... duals with ocular hypertension

@ast

Validated prediction model for ...... duals with ocular hypertension

@en

prefLabel

Validated prediction model for ...... duals with ocular hypertension

@ast

Validated prediction model for ...... duals with ocular hypertension

@en

P1433

Q36016893-5CE289B5-FFFE-4495-AFD0-405650C71143

P1476

Q36016893-C258CE29-D085-42F6-90E4-7C16B943964F

P2093

Q36016893-17B13EA0-E333-4DF3-8976-B923318C3A2E

Q36016893-3A8A6569-7C7E-4219-BB3C-829A4A3820F4

Q36016893-43BDB85D-65E8-4D2A-8F2A-AC83AF77A731

Q36016893-45C5CAB1-6175-4AF7-8DE0-D3453F5C5D6E

Q36016893-7C2DC283-8890-441F-A07A-062B7D8E59D4

Q36016893-9EA99223-CC75-4E3A-9C12-D61E2B302380

Q36016893-A27303DB-9C3B-4C53-A9C1-333F10660801

Q36016893-BA54A0BB-8902-4468-93B7-32013EC7B7D2

Q36016893-BF685EDD-0B79-4BD1-82E7-440004FFAB38

Q36016893-E60420E0-058A-4F6A-A91C-25FFC1A73B62

P2860

Q36016893-0506A18D-2B62-4D7A-8623-0A8F65646A73

Q36016893-0BE83A89-C6EC-4301-AA96-1457035D7A80

Q36016893-14083B08-970E-498F-8DFF-E7152815C36E

Q36016893-1640CC1F-F1C0-4456-AE68-E365B9322721

Q36016893-16C82AB8-B88C-4671-BD5C-03BDE3AD79F4

Q36016893-18C9B1F2-A3EE-4572-9C6E-730E4720CBD5

Q36016893-19F0EE6C-9579-4F52-8638-729A3EB9A2C2

Q36016893-1AE4323B-5ADB-45CD-AF73-0E2129F87DFC

Q36016893-1CA32C5D-3B21-4E61-8C3F-6E44A28FC6A0

Q36016893-1F2EB955-8EB2-4C42-A242-D4BC23A9AC23

P304

Q36016893-4F9A90B7-10AC-4DE1-AF6E-6F5319FBAE31

P31

Q36016893-8136DAB3-E5F4-4F79-A90F-88662D816857

P356

Q36016893-A05E4AE1-6316-415F-9838-CD7A830DFA4E

P433

Q36016893-E1DDF66E-7981-419C-AFE2-41E9021372A6

P478

Q36016893-A6E0981E-04B3-4CFF-8EE4-D0A8EDFB5AD8

P577

Q36016893-26453180-B300-4899-A382-0AC49F10F1CE

P5875

Q36016893-06F8279B-CDD2-4E92-81A6-B51A40AFF9F0

P698

Q36016893-727BFB17-397F-47BC-B69B-42ECA35030ED

P921

Q36016893-16954397-53B3-48B9-B843-F4EB1CA12AA5

P932

Q36016893-5674CECF-DB49-41D4-92FB-509274BABF78

P356

J.OPHTHA.2006.08.031

P1433

P1476

Validated prediction model for ...... duals with ocular hypertension

@en

P2093

Davide Poli

http://www.w3.org/2001/XMLSchema#string

European Glaucoma Prevention Study Group

http://www.w3.org/2001/XMLSchema#string

Feng Gao

http://www.w3.org/2001/XMLSchema#string

Ingrid Adamsons

http://www.w3.org/2001/XMLSchema#string

Irene Floriani

http://www.w3.org/2001/XMLSchema#string

J Philip Miller

http://www.w3.org/2001/XMLSchema#string

Julia A Beiser

http://www.w3.org/2001/XMLSchema#string

Mae O Gordon

http://www.w3.org/2001/XMLSchema#string

Michael A Kass

http://www.w3.org/2001/XMLSchema#string

Ocular Hypertension Treatment Study Group

http://www.w3.org/2001/XMLSchema#string

P2860

Evaluating the yield of medical tests.

Racial differences in the cause-specific prevalence of blindness in east Baltimore.

Management of ocular hypertension: a cost-effectiveness approach from the Ocular Hypertension Treatment Study

Number of people with glaucoma worldwide

Five-year incidence of open-angle glaucoma: the visual impairment project.

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

Risk factors associated with the incidence of open-angle glaucoma: the visual impairment project.

Risk factors for the development of glaucomatous visual field loss in ocular hypertension.

Models of open-angle glaucoma prevalence and incidence in the United States.

Multivariate analysis of the risk of glaucomatous visual field loss.

P304

10-19

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.OPHTHA.2006.08.031

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

114

http://www.w3.org/2001/XMLSchema#string

P577

2006-11-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6702448

http://www.w3.org/2001/XMLSchema#string

P698

17095090

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension

P932

1995665

http://www.w3.org/2001/XMLSchema#string